Please login to the form below

MINT

This page shows the latest MINT news and features for those working in and with pharma, biotech and healthcare.

Takeda grows in Turkey with Neutec subsidiary acquisition

Along with fellow MINT bloc countries Mexico, Indonesia and Nigeria, Turkey is considered an attractive market for the pharma industry thanks to its increasingly affluent population and long-term growth potential,

Latest news

Turkey aims to become ‘global player’ in biopharma

As one of the new MINT block of emerging markets (along with Mexico, Indonesia and Nigeria), the country has attracted quite a lot of investment from pharma multinationals, keen to tap
Bayer fails to block Indian Nexavar compulsory licence

CEO Rajeev Nannapaneni told Live Mint in July that “ there are certain products which are eligible for compulsory licensing”, but refused to be drawn on what they were.
Digital healthcare marketing trends to watch out for in 2012

apps like Foursquare to money management tools like Mint.
Safety in numbers

The law calls for serialised codes in a 2D datamatrix format which will be printed on self-adhesive security labels supplied by the Brazilian mint.
Survival tactics

Mundipharma International (MINT) and its independent associated companies are perhaps more like an investor with go-to-market capabilities than a traditional pharmaceutical company. ... MINT realised this and moved quickly to facilitate the acquisition

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Deep Dive - MINT: opportunities in ‘ frontier’ markets? According to British economist Jim O’ Neill, MINT is the new BRIC. ... What is MINT? An acronym he coined for the ‘ frontier’ markets of Mexico, Indonesia, Nigeria and Turkey.
Is MINT the next BRIC?

Is MINT the next BRIC? In 2001, British economist Jim O’ Neill coined the now ubiquitous acronym ‘ BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, ... We will continue to monitor the MINT market, and aim to
Turkey: Identifying the Growth Drivers

Last year, I concluded my series of articles outlining the challenges and opportunities for pharma in the “ MINT” countries, by stating that aggressive pricing controls and dominance of generic drugs, means ... Whilst the private sector represents
Exploring MINT: Part 4 - Turkey

Why Turkey? With a population of approximately 75 million, Turkey has the smallest population of all of the ‘ MINT’ markets. ... As a result the greatest opportunities for pharma, within the MINT markets, at this stage often lie within the private
Exploring MINT: Part 3 - Nigeria

From a healthcare perspective, Nigeria has some parallels with the other MINT markets of Mexico and Indonesia. ... Given the infrastructural, political and fiscal challenges, Nigeria’ s potential may also take longer to realise, relative to the other

More from PMHub
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Editorial Team Leader, Medical Communications: Excellent package

Account Manager: £40, 000 - £45, 000 benefits

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Home based, Chief Medical Writer, Medical Communications: Excellent package

Senior Account Manager: Competitive salary commensurate with experience

Home based, Senior Medical Writer, Medical Communications: Excellent package

Business Unit Head, Medical Communications, London: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Client Services Director – Healthcare Advertising - London: Neg

Healthcare PR Director: £100, 000 – £120, 000 benefits

Home based, Principal Medical Writer, Medical Communications: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Delivery Manager/ Head of Delivery – Executive Search: Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Client Services Director - Med Comms: Great salary and bebefits

Senior Project Manager - Medical Writing: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....